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Introduction 
 
Metabolomics is the comprehensive qualitative and/or 
quantitative study of a metabolome (the set of metabolites synthesized 
by an organism, tissue, or cells) and as such provides measurements 
essential for systems biology approaches for the study of health and 
disease. It has benefited greatly from advances in analytical 
technologies including nuclear magnetic resonance (NMR) and mass 
spectrometry (MS) coupled to separation techniques. The advantages 
of NMR are the minimal requirements for sample preparation and 
the non-discriminating and non-destructive nature of the technique. 
However, the low sensitivity of NMR makes it difficult to detect 
low-abundance metabolites that could constitute key discoveries of 
new biomarkers or biological mechanisms. Mass spectrometry-based 
metabolomics offers high selectivity and sensitivity and, more 
importantly, the potential to identify metabolites. Combining MS 
with separation techniques reduces the complexity of the mass spectra 
due to metabolite separation in the time dimension and provides 
additional information about the physical and chemical properties of 
the metabolites [1,2]. Due to these advantages, the MS-based 
metabolomics approach is being widely used in food and nutrition 
research [3], plant science [4], marine science [5], environmental 
science [6], drug development and toxicology studies [7,8], and many 
others. 
Obtaining a full coverage of the metabolome generally requires 
multiple separation approaches since metabolites are heterogeneous, 
low molecular-weight components (less than 1,500 Da) that are 
characterized by a wide variation in physical and chemical properties 
(e.g., polarity, volatility, and solubility) [9]. Three types of separation 
techniques are commonly used in MS-based metabolomics: liquid 
chromatography (LC), gas chromatography (GC), and capillary 
electrophoresis (CE).  
 
 
 
 
 
 
 
 
 
  
GC combined with electron ionization (EI) mass spectrometry 
allows for the identification and quantification of volatile and 
thermally stable compounds of low polarity from sources such as 
biological tissues and foods [10]. The fragmentation of metabolites 
during EI are highly characteristic of the chemical structure, allowing 
these mass spectra to be used for identification of compounds from 
mass spectral libraries [11]. Due to its high reproducibility, 
chromatographic peak resolution, and the existence of libraries of 
mass spectra, GC-EI-MS is regarded as the gold standard for 
metabolomics research [12]. However, GC-MS is incompatible with 
nonvolatile and thermally labile compounds. As a result, 
derivatization methods have been developed to make these 
metabolites less polar, more volatile and/or thermally stable so that 
they can be analyzed on GC-MS.  
Complementary to GC-MS, LC-MS enables identification and 
quantification of high polarity compounds including organic acids, 
fatty acids, amino acids, and steroids. LC-MS-based metabolomics is 
generally performed using soft ionization techniques such as 
electrospray ionization (ESI) and atmospheric pressure chemical 
ionization (APCI), which do not cause fragmentation of the 
molecular ions and thus allow for the determination of elemental 
compositions. In addition, LC-MS/MS can be used to identify 
metabolites [10,13].  
The third separation technique, CE, is suited for the separation of 
polar and charged compounds, as compounds are separated on the 
basis of their electrophoretic mobility. However, the repeatability of 
migration time in CE is very poor compared to that of the retention 
time in GC and LC. This factor is especially critical in metabolomics 
because a high accuracy of metabolite peak alignment must be 
achieved prior to downstream data analyses. Large variations in 
migration time make alignment very challenging [14].  
MS-based metabolomics experiments using these separation 
techniques can be conducted using three approaches: 1) non-targeted 
metabolic profiling where the identity and relative quantity of as many 
metabolites as possible are obtained; 2) targeted profiling where the 
absolute quantity of a pre-selected smaller set of metabolites, typically 
related by chemical or biological similarity, are obtained using internal 
standards and reference compounds, and 3) metabolic fingerprinting 
where a global snapshot of the metabolism is acquired and compared 
without   performing   quantification   and   chemical   identification.  
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Biologically interesting components can then be subjected to targeted 
profiling for identification and quantification.   
These aforementioned analytical platforms (LC-, GC, and CE-
MS) and metabolomic approaches (profiling and fingerprinting) have 
been applied widely in metabolomics research. A number of excellent 
review articles have been published summarizing this work [3,15-24]. 
Carrying out a metabolomics study generally involves a sequence of 
steps: experimental design, sample collection and preparation, analysis 
of samples on analytical platforms, and data handling. Among these 
steps, the last step relies heavily on bioinformatics. Because mass 
spectrometry-based metabolomics studies generally produce large and 
complex datasets, the bioinformatics involved is nontrivial and 
requires specialized computational algorithms and software tools. 
For metabolic profiling where identification and quantitation 
(semi-quantitation for non-targeted and absolute quantitation for 
targeted profiling) are performed, bioinformatics includes three 
sequential steps: (1) data processing converts mass spectral data into 
tables of known or unknown metabolites with their identity and 
Figure 1. Comparison of constructed mass spectra and subsequent metabolite identification results with and without accurate deconvolution of shared peaks 
from two co-eluting compounds, uridine (Left) and n-Eicosanoic acid (Right). (A) Raw EICs of selected masses. Mass 43, 73, and 117 marked with red circles are 
shared by both compounds. Mass 217 is unique to uridine while mass 132 is unique to n-Eicosanoic acid. (B1-2) Constructed mass spectra of uridine (B1) and n-
Eicosanoic acid (B2) after deconvolution using ADAP 1.0. The shared masses 43, 73, and 117 are only included either in the spectrum for n-Eicosanoic acid or in 
uridine. Their matching scores are 810 and 881, respectively. (C1-2) Constructed mass spectra after deconvolution that decomposes shared peaks. Each of the 
shared masses, 43, 73, and 117, is included in the spectra for both n-Eicosanoic acid and uridine. Their matching scores are 909 and 948, respectively. (D1-2) 
Reference spectra from an in-house library. This Figure is Figure 1 in the original article [33].  Reprinted with permission from the American Chemical Society. 
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quantity, (2) data analysis identifies interesting metabolites or 
metabolic patterns through statistical analyses, clustering, and 
classification, and (3) data interpretation places the metabolomics 
data in the context of metabolic pathways and integrates 
metabolomics data with data from other omics platforms. 
Combination of the three steps is essential for knowledge discovery 
from the metabolomics experiments. 
Among the three data handling steps, processing of raw mass 
spectral data is critical because any inaccuracy in this stage will 
propagate to the subsequent two steps. For a GC-MS based 
metabolomics study, data processing is even more critical due to co-
elution of two or more compounds and the in-source fragmentation 
of molecular ions caused by the hard EI ionization. Co-elution and 
in-source fragmentation cause the resulting raw mass spectra to 
consist of mass peaks from all of the co-eluting metabolites. In order 
to identify and extract the quantitative information of the 
corresponding metabolites, the spectrum for each single metabolite 
has to be constructed based on the composite spectra. This spectrum 
construction step is called deconvolution in GC-MS data processing. 
Considering the importance of GC-MS for analyzing compounds 
commonly observed in fruits, vegetables, nutritional and medicinal 
plants, and human biofluids after food digestion, we would focus on 
the deconvolution aspect of GC-MS data processing in this review. 
We will review the progress that has been made so far, and provide 
our thoughts on future developments that will enable further progress 
in metabolomics research. For the other aspects of data processing 
and the subsequent data analysis and interpretation, we refer readers 
to the research article by Stein el al. [25], review articles by Wishart 
[26,27] and by Halket et. al. [10].    
 
Deconvolution 
 
For GC-MS data, deconvolution is the process of 
computationally separating co-eluting components and creating a pure 
spectrum for each component. Specifically, for each observed EIC 
that results from two or more components, deconvolution calculates 
the contribution of each component to the EIC. Figure 1 depicts the 
necessity of deconvolution. 
Deconvolution had evolved based on the work of a number of 
researchers [28,29] and was popularized with the publication of the 
AMDIS (Automated Mass Spectrometry Deconvolution and 
Identification System) algorithm [30] and subsequent development of 
the software tool [31]. The principle behind AMDIS also formed the 
basis for subsequent developments of other deconvolution algorithms 
including MetaboliteDetector [32] and ADAP-GC [33]. These three 
software tools are freely available. Commercial software tools have 
also been developed that include ChromaTOF [34] and AnalyerPro 
[35]. As far as we know, the technical details of the latter two 
software tools have not been released. Next we will examine the 
deconvolution algorithms implemented in AMDIS, 
MetaboliteDetector, and ADAP-GC. 
 
The overall deconvolution process in AMDIS consists of four 
sequential steps: 1) noise analysis, 2) component perception, 3) model 
shape determination (The original paper included this step as part of 
step 2 [30]. For convenience of comparison with other algorithms in 
this review, we describe this step separately), and 4) spectrum 
deconvolution. The first step extracts the noise characteristics for a 
GC-MS data file by calculating the noise factor to be used for 
representing signal magnitude in noise units. Noise factor is 
conceptually defined as 
signaldeviation random averagefN
 
Briefly, each EIC and the total ion chromatogram (TIC) are 
divided into segments of a certain number of scans (13 scans were 
used in the original publication [30]). For each segment that has no 
zero abundance values, a mean abundance is computed and the 
number of times that this mean value is crossed is counted. If the 
number of crossings is greater than one-half of the number of scans 
(i.e., 7 scans when the segment is 13 scans wide), this segment is 
accepted and the median deviation from the mean abundance for that 
segment is found (Figure 2). This deviation is the average random 
deviation within this segment. It is then divided by the square root of 
the mean abundance for that segment to obtain a segment-specific 
N f value as defined in Eq. 1. The median of all of the segment-
specific N f values is taken as the characteristic N f  value for the entire 
GC-MS data file. The square root of a signal multiplied by N f  is the 
magnitude of this signal in ‘noise units’.  
 
 
 
 
 
 
 
 
 
 
 
 
The second step, component perception, perceives individual 
chromatographic components. The rationale behind component 
perception is that a component exists when a sufficient magnitude of 
ions maximize together. It is achieved through a process as illustrated 
in Figure 3 where the deconvolution window is established first. 
When determining a deconvolution window, AMDIS “sequentially 
examines scans starting at the scan of maximization and proceeds in 
the forward and reverse directions up to a pre-set maximum number 
of scans (12 is the default). If a signal abundance is encountered that 
is more than five noise units greater than the smallest abundance 
between that scan and the starting scan (with noise units measured for 
the smallest abundance), then it is presumed that another component 
has been found and the window length is set to the preceding scan. 
Also, if the intensity falls below 5% of the maximum intensity, the 
window is fixed at that scan.” 
The third step determines the model peaks to be used in the next 
step for deconvolution. The model shape for each perceived 
component is taken as the sum of the individual ion chromatograms 
that maximize together and whose sharpness values are within 75% of 
the maximum value for this component. The sharpness value between 
the maximum abundance, Amax, and an abundance value located n
scans from the maximum, An is defined as:  
Figure 2. Illustration of the determination of the noise factor (N f) from 13-
scan ion chromatogram segments. The upper chromatogram is rejected 
because it has fewer than seven “crossings” of the mean. The lower ion 
chromatogram crosses the mean eight times, so provides a sample noise 
factor. The median distance from the mean (seventh closest to the mean) 
is used to generate a sample noise factor N f. The final N f for the analysis 
is taken as the median of all sample values. This Figure is Figure 1 in the 
original article [30]. Reprinted with permission from Elsevier. 
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The maximum sharpness values on each side of the maximum 
scan are averaged as the sharpness value of this ion chromatogram.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The last step, deconvolution, extracts ‘purified’ spectra from 
individual ion chromatograms for each component using the model 
shapes and the least-squares method. Briefly, each ion chromatogram 
is fit to the model profiles allowing a linear baseline: 
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This four-step process of deconvolution that AMDIS uses forms 
the basis of deconvolution in MetaboliteDetector [32] and ADAP-
GC 2.0 [33]. Even though the deconvolution principle underlying 
these three algorithms are similar, the algorithms differ in details that 
we describe next.  
  
Deconvolution in MetaboliteDetector differs from AMDIS in 
component perception and model peak determination. For 
component perception, it detects the beginning and ending of 
chromatographic peaks by calculating the first derivative of the 
smoothed intensity values (Figure 4): 
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A resulting peak is counted as valid if three criteria are met: the peak 
must consist of more than three values, the height above the baseline 
in signal-to-noise units of the maximum peak value must exceed a 
predefined threshold, and the quality of the peak shape must be in a 
certain range. The quality of a peak shape, named discrepancy index, 
is defined based on the assumption that all values of the first 
derivative of an ideal single peak must be positive from the peak 
beginning to the peak maximum and negative from the peak 
maximum to the peak ending. The absolute values of the first 
derivatives that agree with this assumption are summed as ideal slopes 
and the absolute values of the first derivatives that disagree with this 
assumption are summed as nonideal slopes. The discrepancy index qp 
of a peak shape is formally defined as the ratio of the nonideal to 
ideal slopes:  
 
%100
slopes ideal of sum
slopes nonideal of sum
pq
 
 
Reasonable values of qp are in the range between 0% and 10%. 
 
To determine the model peak shape for each perceived 
component, MetaboliteDetector sorts all single ion peaks of a 
compound having qp values below 10% by their sharpness values. 
The top 25% of the peaks in terms of the sharpness value are 
summed to form the model peak for this compound.  
 
 
 
 
 
 
 
 
 
 
 
Deconvolution in ADAP-GC 2.0 differs from AMDIS and 
MetaboliteDetector in terms of component perception, noise analysis, 
and model peak determination (Figure 5). Specifically, ADAP defined 
the concept of chromatographic peak features (CPFs).  
A CPF is the elution profile of a minimum number of 
components that makes the elution profile complete, with ‘complete’ 
meaning that the elution profile lasts from the beginning to the end of 
the elution of the component(s). A CPF that results from a single 
component is defined as a simple CPF, and a CPF that results from 
two or more components is defined as a composite CPF. A simple 
CPF has only one local maximum, and a composite CPF could have 
one, two, or more local maxima. ADAP-GC 2.0 detects a CPF by 
determining the beginning, ending, and apex time of each local peak 
based on local maximum (for peak apex) and minimum (for 
beginning and ending). To determine if a peak is a simple CPF or 
part of a composite CPF, the algorithm calculates the ratio of 
intensity values at the boundaries to the intensity value at the peak 
apex. If one of the ratios is higher than a configurable threshold, this 
peak is considered part of a composite CPF. All of the neighboring 
incomplete peaks are then merged to form a composite CPF.  
Figure 3. Four steps for determining whether an ion chromatogram peak 
is large enough to be used for peak perception. (1) A scan window is set 
using minima on each side of the peak; (2) a tentative baseline is drawn 
between the lowest points on each side (readjusted if a point between 
these end points falls below the line); (3) a least-squares line is drawn 
using the lowest one-half of points as measured from the baseline in step 
2; (4) signal height between the maximum and least squares line is 
computed. Peaks must have heights larger than four noise units (N f  √ ) 
for use in peak perception (A is the absolute abundance at the peak 
maximum). This Figure is Figure 2 in the original article [30]. Reprinted 
with permission from Elsevier. 
 
Figure 4. Single ion chromatographic peak detection. The peak borders are 
determined based on the first derivative of the intensity values. The red 
line represents the intensity values vs. retention time. The blue line 
depicts the first derivative of the intensity values. If the values of the first 
derivative cross the peak threshold, a peak begin or end is set (dotted 
lines). This Figure is Figure 2 in the original article [32]. Reprinted with 
permission from American Chemical Society. 
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Subsequently, ADAP-GC 2.0 determines the deconvolution 
windows based on both the TIC and EIC. Basically, the beginning 
and ending of a TIC CPF delimit a window and any EIC CPF whose 
peak apex falls in the window will participate in the window-specific 
deconvolution. For each deconvolution window, ADAP determines 
the number of components and the model peak shape for each 
component. Unlike the model peak in AMDIS and 
MetaboliteDetector, ADAP-GC 2.0 defines a model CPF as the 
elution profile of a compound when it elutes from a chromatography 
system alone and its concentration is within the linear dynamic range 
of the mass spectrometer. As such, a model peak can result from the 
elution of a single component only. To determine the model CPF, 
Figure 5. Illustration of the data analysis workflow of ADAP-GC 2.0 using two co-eluting compounds. (A) Detection of CPFs from TIC and determination of 
deconvolution windows (indicated by blue vertical lines). Two representative CPFs are displayed: one simple CPF marked by a blue solid circle at the apex and 
one composite CPF marked by red and green solid circles at the apexes. (B-F) Deconvolution of the EIC CPFs that have given rise to this composite TIC CPF. (B) 
Raw EICs of 46 good candidates. (C) The constructed mirror images of the 46 good candidates. (D) Determination of the number of components and 
corresponding model CPFs for each component using hierarchical clustering. The red dashed line indicates the empirical cutoff for determining the number of 
clusters. (E) The composite CPFs of masses 73, 147, 245, and 273 (solid line) were decomposed into simple CPFs (dashed line). (F) Two mass spectra were 
constructed and identified. This Figure is Figure 3 in the original article [33]. Reprinted with permission from the American Chemical Society. 
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ADAP first calculates five quality metrics of each CPF. These five 
metrics are sharpness, signal-to-noise ratio (SNR), peak intensity, 
Gaussian similarity, and the mass. The sharpness value of a CPF is 
calculated as 
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Where N is the total number of time points for a CPF, p
 
is the time 
index of the apex, and Ii is the abundance value at time index i . The 
SNR is estimated based on the high- and low-frequency signal 
components of the CPF, which is calculated using the continuous 
wavelet transform. For details about other metrics, please refer to the 
original article.  
Following the calculation of the five metrics, ADAP selects those 
CPFs with high values of sharpness, SNR, and Gaussian similarity. 
Each of the filter-passing CPFs is assigned a total quality score 
calculated as 
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Those CPFs whose total score pass the following threshold are 
considered good candidates of model CPFs: 
 
    scores totalrange25.0scores totalminscore total threshold   
 
Finally, all of the good candidates for model CPFs participate in a 
hierarchical clustering process for ADAP to determine the most likely 
number of components in the current deconvolution window and the 
corresponding model peak for each component.  
 
Conceptual comparison of deconvolution algorithms in 
AMDIS, MetaboliteDetector, and ADAP-GC  
 
Each of the aforementioned computational steps plays an 
important role in determining whether or not metabolic changes can 
be detected in metabolomics studies.  
 
 Noise analysis: Mass spectra and chromatograms that are 
obtained from the spectra are inherently noisy. All of the three 
algorithms we described above incorporated noise analysis. 
AMDIS and MetaboliteDetector calculate the noise factor of 
a GC-MS data file and then convert the signal magnitude in 
noise units in some of the subsequent calculations. ADAP-GC 
2.0 uses a completely different approach by directly 
computing the signal-to-noise ratio of each CPF and uses it as 
a filter to prevent noisy CPFs from being selected as model 
CPFs. Without direct comparison between these two 
approaches, it is challenging to state which one leads to better 
performance. 
 
 Determination of deconvolution windows: AMDIS’s 
approach often causes deconvolution windows to be narrower 
than optimal for quantitation, as pointed out in the original 
article [30]. This happens in two scenarios where a 
deconvolution window contains only part of the entire 
chromatographic peaks. One is when a chromatographic peak 
is very intense, the deconvolution window is fixed at 5% of 
the maximum intensity, and the remaining part of the peaks 
that is below 5% of the maximum intensity is outside of the 
deconvolution window. If neighboring co-eluting components 
are in very low concentrations, their abundance will be much 
lower than that of the dominating peak and most of their 
chromatograms will be outside of the deconvolution window. 
We have observed many examples of this case in our own 
work. The other scenario is when the algorithm determines 
that a co-eluting component is encountered because the 
abundance value is more than five noise units greater than the 
smallest abundance between that scan and the maximization 
scan. Since the window is set to the preceding scan, part of the 
peak will be left out of the deconvolution window as well.  
 
In order to resolve this issue, ADAP-GC 2.0 tries to detect 
composite CPFs and ensure that their deconvolution windows 
contain the entire CPF. Conceptually, this should increase the 
accuracy of the quantitative information that ADAP extracts 
about metabolites from the data.  
 
In MeteboliteDetector, how deconvolution windows are 
determined was not explicitly described. Regardless of the 
specific approach, it must utilize the information about the 
beginning and ending of chromatographic peaks. 
MetaboliteDetector determines the beginnings and endings 
using first derivatives as in Eq. 4. For details, please refer to 
the original article. This approach tends to be very sensitive to 
noise because the derivative operation amplifies noise [36]. 
Even though chromatograms are smoothed prior to this step, 
fluctuations can still exist along a chromatographic peak and 
cause the algorithm to decide that a beginning or ending of 
the chromatographic peak has been encountered. 
Consequently, part of the peak will be left out of the 
deconvolution window and the quantitative information 
extracted from the data about the corresponding component 
will be reduced. 
 
 Determination of model peaks: The central goal of 
deconvolution is to decompose a composite CPF into the 
weighted summation of the model peaks and then form the 
spectrum of a single component based on the weights in Eqn. 
3. Specifically, the resulting c * M (nmax) in Eqn. 3, where 
nmax denotes the scan with the maximum model peak 
abundance, will be used as the abundance for the 
corresponding m/z in the extracted spectrum. Conceptually, it 
should be preferred that each model peak corresponds to one 
single component only. However, since both AMDIS and 
MetaboliteDetector use a summation of peaks as the model 
peak and one or more of the constituent peaks could consist 
of signals from multiple co-eluting components, the 
likelihood that the final model peak also consists of signals 
from multiple co-eluting components is very high. 
Consequently, the magnitude of the mass peaks in the 
extracted spectrum will be inaccurate, which could ultimately 
cause both false positive and false negative metabolite 
identifications. Moreover, the quantitative information for 
corresponding components will be inaccurate as well since it is 
calculated based on the extracted spectrum.  
 
ADAP, however, selects only the purest peak for model peaks 
by using five peak quality metrics. On the other hand, ADAP 
has a weakness too in determining model peaks. It favors 
model peaks that are symmetric and resemble a Gaussian 
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curve. In reality, fronting and tailing do occur and cause 
asymmetric peak shapes even when a compound elutes alone 
from the chromatography system. This issue can conceptually 
be alleviated or eliminated by decreasing the weighting factor 
c2 that is assigned to the Gaussian similarity in Eq. 7. Of 
course, testing is needed to check if the overall performance of 
the algorithm is affected as a result of this change. 
 
Based on the above description, we can see that it will be 
worthwhile to carry out a detailed comparison about the performance 
of the critical computational steps and come up with the best overall 
deconvolution strategy. Even though the aforementioned three 
algorithms have not been directly compared, a comparison between 
AMDIS and two commercial software packages, ChromaTOF [37] 
and AnalyzerPro [35], has been performed by Lu et. al [12]. The 
article concluded that none of these approaches provided a 
comprehensive solution meeting the specific needs of metabolomics 
[12]. Specifically, 1) AnalyzerPro tends to produce a great number of 
false negatives, 2) ChromaTOF and AMDIS tend to produce 
multiple peak assignments that clearly correspond to a single 
chromatographic peak and chemical entity, and 3) all of them are still 
fairly slow for the flood of data from high-throughput metabolomics 
studies. Since details about the deconvolution algorithms in 
ChromaTOF and AnalyzerPro are unknown, we are unaware of the 
possible factors that could have caused their respective issues.  
For AMDIS, it was originally developed for automated 
identification of chemical weapons and related compounds [30]. 
Therefore, there is a strong emphasis in AMDIS on low false negative 
rates for metabolite identification. Since identification is achieved by 
matching the ‘purified’ spectra for single components that are 
obtained from deconvolution against libraries of reference mass 
spectra, each step of the deconvolution process needs to ensure that as 
few components as possible are missed. As a result, AMDIS is best 
suited for analyzing simple mixtures consisting of a small number of 
compounds. When analyzing complex mixtures, time-consuming 
manual checking of the results is necessary in order to reject false 
positive identifications [32].  
Appropriate configuration of processing parameters can help 
alleviate the challenge to find an acceptable balance between false 
positive and false negative identifications. However, without prior 
knowledge about the sample composition in un-targeted metabolic 
profiling experiments, researchers usually do not know what 
parameter setting is appropriate for their datasets. This issue exists in 
other algorithms as well. 
 
Summary and Outlook 
 
The past decade has witnessed tremendous progress on 
metabolomics bioinformatics research. However, the progress has not 
been as fast as that on the instrumentation side as mass spectrometry 
coupled to chromatography is becoming increasingly sensitive and 
their operations are becoming increasingly high-throughput. Next, we 
provide our thoughts on new bioinformatics capabilities for GC-MS 
data processing that are needed for metabolomics to progress further. 
 
 More efficient and reliable deconvolution algorithms need to 
be developed for identification and quantification of metabolites due 
to the aforementioned limitations of existing deconvolution 
algorithms. Newly developed algorithms need to be implemented into 
user-friendly and high-throughput software tools. These software 
tools should be equipped with visualization capabilities that will allow 
metabolomics researchers to visually examine intermediate and final 
results for verifying the correctness of significant metabolites detected 
in the data analysis and data interpretation stages. Development of 
these algorithms and software tools will benefit greatly from an 
interdisciplinary team of researchers and software engineers with 
engineering, chemistry, math, and computer science background. 
 
 Computational algorithms and software tools are also needed 
for identifying unknown metabolites. This is because, with 
unprecedented sensitivity, dynamic range, and throughput, both GC-
MS and LC-MS analytical platforms can now detect many 
metabolites in a short time frame that could not be observed before. 
However, the power of the detection methods has outstripped our 
ability to process the data. Often, the number of unidentified 
metabolites in a sample is 2-3-fold more than the number of 
identified metabolites even after extensive data processing. This is 
because even the largest and most comprehensive of currently available 
libraries contain only a small portion of the endogenous metabolites 
found in biological samples [38-41].  
Identifying these unknown metabolites is currently a major 
bottleneck in metabolomics [42,43]. This issue is even more acute in 
studies investigating plant products because diverse plant species are 
estimated to produce more than 200,000 metabolites of enormous 
biochemical diversity of which only 10,000 chemical structures are 
known [4,11]. Even the extensively studied model plant Arabidopsis 
thaliana has a large number of enzymes whose substrates and products 
remain unknown [44]. Meanwhile, commercially available standard 
reagents, especially those of secondary metabolites produced by 
plants, are very limited in number. Given the fundamental importance 
of biochemicals to agriculture, nutrition, and health, the potential 
benefit of identifying even half of these unknown metabolites is 
astronomical. 
Therefore, a pressing need in the metabolomics community is the 
development of effective methods for prioritizing, studying, and 
ultimately identifying uncharacterized metabolites [40]. To address 
this need, novel bioinformatics capabilities to process raw mass 
spectral data and to create libraries of unidentified spectra must be 
developed [10,11,26,38,45,46].  
For GC-MS-based metabolomics, some progress has been made in 
the effort to use and catalogue unidentified GC-MS spectra in 
metabolomics studies [4,37,38,46-64]. Among these efforts, most 
rely on nonsystematic, low-throughput, manually assisted curation of 
unidentified peaks [38], and only a few use more advanced 
approaches with minimal manual annotation. These latter efforts 
include the work on developing the volatile compound mass spectral 
database named vocBinBase [63], developing a spectral library of 
unknown compounds for urine [46], and identifying conserved 
metabolites [38]. These three projects used spectra extracted from the 
raw mass spectral data by AMDIS or ChromaTOF (LECO Corp., 
Michigan, USA). In constructing the vocBinBase database, unknown 
spectra are filtered and only the filter-passing spectra are imported 
into the database. Unfortunately, since each spectrum in the database 
is obtained from only a single sample, it is very likely that it is not the 
best representation of the corresponding compound. Missing, 
inaccurate, or false peaks in these spectra will cause future false 
positive and false negative identifications, especially as the database 
grows and different compounds with similar spectra are incorporated 
into the library. A better approach is to construct a consensus 
spectrum from many measurements of the same compound. 
Consensus spectra are indeed used in some of these developments 
[38]. However, inaccuracies in these spectra still need to be corrected 
based on analyses of extracted spectra from multiple samples. This 
step is very important because inaccuracies are very likely to occur due 
to factors such as co-elution, low signal-to-noise ratios in some 
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regions of the chromatograms, and inappropriate parameter settings in 
the process of chromatographic peak picking and deconvolution [12]. 
This spectra correction step will significantly increase our confidence 
in the consensus spectra. In addition, it will improve the accuracy of 
the quantitative information about the corresponding unknown 
metabolites, which is critical to comparative metabolomics 
In addition to the above approaches, the widely used GOLM GC-
MS mass spectral database incorporated mass spectra of unidentified 
metabolites. However, similar to the vocBinBase database, no 
derivation of consensus spectra or determination of the best 
representative spectra was implemented [65]. For LC-MS-based 
metabolomics, the creation of multiple databases of LC-MS/MS 
mass spectra has made significant contributions to the field, including 
METLIN [13] and MassBank [66]. However, there has been no 
report of systematically creating spectral libraries of unknown 
compounds. 
This lack of capabilities to handle unidentified GC-MS and LC-
MS spectra reveals that metabolomics bioinformatics is lagging 
behind technological advances in analytical instrumentation, and this 
is hindering investigators from taking advantage of data that the 
instruments already capture. 
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